Global Ultrasound Devices Market - Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387387
  • Report
  • Region: Global
  • 208 pages
  • Mordor Intelligence
1 of 4
The global ultrasound devices market was valued at USD 5,700 million in 2015 and is projected to reach USD 7,033 million by 2021, at a CAGR of 3.7% during the forecast period from 2016 to 2021. Improvements in the ultrasound technology are increasing the demand for ultrasound devices, globally.

Market Dynamics

Government and private funding for R&D in ultrasound imaging, aging population, increasing number of healthcare providers, curtailment in the size of ultrasound devices, and higher incidences of chronic diseases are some of the factors that are propelling the growth of the market. However, lack of skilled labor to handle the equipment and stringent FDA regulations are turning out to be restraints for this market.

Market Segmentation

The global ultrasound market has been segmented by

Application - Anesthesiology, obstetrics/gynecology, cardiology, musculoskeletal, radiology, emergency department, critical care and others.
The cardiology sub-segment contributes the highest share.

*Some values in the chart may be randomized. Actual data available on report purchase

Technology - 2D ultrasound imaging, 3D & 4D ultrasound imaging, Doppler imaging High-intensity focused ultrasound.
2D ultrasound accounts for the largest market share

*Some values in the chart may be randomized. Actual data available on report purchase

Type - Stationary ultrasound imaging and Portable ultrasound imaging.
Currently, the demand for handheld ultrasound devices is on the rise owing to the shifting trend towards home healthcare and remote patient monitoring to reduce hospitalization cost.

*Some values in the chart may be randomized. Actual data available on report purchase

Geography- North America, Europe, Asia-Pacific, Latin America, Middle East and Asia.
North America has the largest market size with more than 30% of the global market, which is slightly higher than the European market. Asia-Pacific is considered to be an emerging market for ultrasound devices, due to the increase in population and large investments in the field of R&D of ultrasound equipment.

*Some values in the chart may be randomized. Actual data available on report purchase

Many players in this market are trying to expand their product portfolio to top the global market. Few companies have even adopted product innovation and new product launches as their key business strategies, to ensure their dominance in the market.

The major players in this market include -

Key Deliverables:

Market analysis for the global ultrasound market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global ultrasound market.
Insights of the market in the regions that have the highest potential for growth and to also identify the markets that are still untapped
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Porter’s Five Forces
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing applications in clinical diagnosis boosting the market growth
6.1.2 Speed, cost and accuracy to spur the market growth
6.1.3 Efficient replacement for traditional technologies (Microarrays)
6.1.4 Drug discovery applications demanding NGS technology
6.2 Market Restraints
6.2.1 Legal & ethical issues to hamper the market growth
6.2.2 Interpretation of complex data
6.2.3 Lack of skilled prpfessionals
6.3 Key Challenges
6.4 Current Opportunities in the Market
7. Market Segmentation
7.1 By Technology
7.1.1 Whole Genome Sequencing
7.1.2 Targeted Resequencing
7.1.3 Whole Exome Sequencing
7.1.4 Rna Sequencing
7.1.5 Chip Sequencing
7.1.6 De Novo Sequencing
7.1.7 Methyl Sequencing
7.2 By Products
7.2.1 Instruments
7.2.2 Reagents & Consumables
7.2.3 Services
7.3 By End Users
7.3.1 Hospitals & Healthcare Institutions
7.3.2 Academics
7.3.3 Biotech & Pharma Firms
7.3.4 Others
7.4 By Application
7.4.1 Drug Discovery
7.4.2 Genetic Screening
7.4.3 Diagnostics
7.4.4 Personalized Medicine
7.4.5 Agriculture And Animal Research
7.4.6 Infectious Diseases
7.4.7 Others
7.5 By Geography
7.5.1 North America (NA)
7.5.1.1 United States
7.5.1.2 Canada
7.5.1.3 Mexico
7.5.2 Europe
7.5.2.1 UK
7.5.2.2 Germany
7.5.2.3 France
7.5.2.4 Italy
7.5.2.5 Spain
7.5.2.6 Rest of Europe
7.5.3 Asia Pacific
7.5.3.1 China
7.5.3.2 Japan
7.5.3.3 India
7.5.3.4 Australia
7.5.3.5 Rest of APAC
7.5.4 Rest of the World
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 New Product Launches
8.3 Agreements, Collaborations & Partnerships
9. Future Outlook of the market
9.1 Roche Holding Ag
9.2 Agilent Technologies, Inc.
9.3 BGI (Beijing Genomics Institute)
9.4 Biomatters, Ltd.
9.5 Qiagen
9.6 Dnastar, Inc.
9.7 Gatc Biotech Ag
9.8 Genomatix Software Gmbh
9.9 Illumina, Inc.
9.10 Knome, Inc.
9.11 Thermo Fisher Scientific
9.12 Macrogen, Inc.
9.13 Oxford Nanopore Technologies, Ltd.
9.14 Pacific Biosciences
9.15 Partek Incorporated
9.16 Perkin Elmer, Inc.
9.17 Qiagen N.V.
10. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll